⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29448509 | 1.00 | — | — | |
| Water SCHEMBL8524004 | 0.98 | HSP90AA1 (0.41) | — | |
| SCHEMBL28803015 | 0.81 | — | — | |
| SCHEMBL21918669 | 0.81 | — | — | |
| SCHEMBL3154891 | 0.81 | — | — | |
| SCHEMBL19413126 | 0.81 | HSP90AA1 (0.39) | — | |
| SCHEMBL3718708 | 0.81 | — | — | |
| SCHEMBL29857995 | 0.81 | — | — | |
| SCHEMBL31291331 | 0.81 | — | — | |
| SCHEMBL5340555 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1896 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116924976-A | Diaryl heterocyclic amine compound, preparation method, pharmaceutical composition and application thereof | 中国医学科学院药物研究所 | 2023-10-24 | — | — | CN | claimed |
| CN-103022556-A | Lithium-ion battery and electrolyte thereof | NINGDE AMPEREX TECHNOLOGY LTD | 2013-04-03 | — | — | CN | claimed |
| US-12466804-B2 | Cyclobutyl carboxylic acids as LPA antagonists | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-11-11 | — | — | US | disclosed |
| US-20240239811-A1 | 5-(5-(PIPERIDIN-4-YL)THIENO[3,2-C]PYRAZOL-2-YL]INDAZOLE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE T | REMIX THERAPEUTICS INC. | 2024-07-18 | — | — | US | disclosed |
| US-20240239777-A1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2024-07-18 | — | — | US | disclosed |
| US-20240239835-A9 | NEUROACTIVE STEROIDS AND THEIR METHODS OF USE | SAGE THERAPEUTICS, INC. | 2024-07-18 | — | — | US | disclosed |
| WO-2024151833-A1 | SPIRO DERIVATIVES AS M4 ACTIVATORS/MODULATORS AND USES THEREOF | CEREVEL THERAPEUTICS, LLC (US) | 2024-07-18 | — | — | WO | disclosed |
| US-20240239757-A1 | PHTHALAZINONE DERIVATES AS NLRP3 INFLAMMASOME INHIBITORS | JANSSEN PHARMACEUTICA NV (BE) | 2024-07-18 | — | — | US | disclosed |
| WO-2024151547-A1 | TARGETED DEGRADATION OF VAV1 | MONTE ROSA THERAPEUTICS, INC. (US) | 2024-07-18 | — | — | WO | disclosed |
| US-12036209-B2 | Compounds and methods for the targeted degradation of Interleukin-1 receptor-associated kinase 4 polypeptides | ARVINAS OPERATIONS, INC. (US) | 2024-07-16 | — | — | US | disclosed |
| US-20240228491-A1 | METHIONINE ADENOSYLTRANSFERASE INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | SCINNOHUB PHARMACEUTICAL CO., LTD. (CN) | 2024-07-11 | — | — | US | disclosed |
| WO-2002090328-A1 | THE PREPARATION OF SUBSTITUTED PYRIDINES UTILIZING NITRIC AND AN ANHYDRIDE | REILLY INDUSTRIES, INC. (US) | 2002-11-14 | — | — | WO | disclosed |
| CN-1372552-A | Pyrimidine derivatives and herbicides containing the same | KUMIAL CHEMICAL INDUSTRY CO LT (JP) | 2002-10-02 | — | — | CN | disclosed |
| CN-1029231-C | Preparation method of triazole antifungal agent | PFIZER (US) | 1995-07-05 | — | — | CN | disclosed |
| US-5364938-A | Triazole antifungal agents | PFIZER INC. (US) | 1994-11-15 | — | — | US | disclosed |
| EP-0357241-B1 | Triazole antifungal agents | PFIZER LTD (GB) | 1994-02-16 | — | — | EP | disclosed |
| US-5206364-A | Triazole antifungal agents | PFIZER INC. (US) | 1993-04-27 | — | — | US | disclosed |
| US-5116844-A | TRIAZOLE ANTIFUNGAL AGENTS | PFIZER INC. (US) | 1992-05-26 | — | — | US | disclosed |
| CN-1040795-A | The preparation method of triazole species antimycotic agent | PFIZER (US) | 1990-03-28 | — | — | CN | disclosed |
| EP-0357241-A1 | Triazole antifungal agents | Pfizer Limited (GB) | 1990-03-07 | — | — | EP | disclosed |